---
title: "Pharmaceutical stocks continued to rise in the afternoon, with LIVZON GROUP and nearly ten other stocks hitting the daily limit"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/248724388.md"
description: "In the afternoon, the pharmaceutical stocks continued to rise, with both innovative drugs and generic drugs performing well. Stocks such as LIVZON GROUP, MEDISAN, Qianhong Pharmaceutical, Wanbangde, Asia-Pacific Pharmaceutical, and ZHEJIANG ZHENYUAN all hit the daily limit, while Guangshengtang, Laimei Pharmaceutical, and Wohu Biological rose over 10%. On the news front, the National Organization for Drug Procurement Office announced the selection of the 11th batch of centralized procurement varieties on the 15th. After three stages of screening, 55 varieties were included in the reporting scope of the 11th batch of centralized procurement. The procurement rules will generally adhere to the principles of \"stabilizing clinical use, ensuring quality, preventing collusion, and countering internal competition.\""
datetime: "2025-07-16T06:11:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248724388.md)
  - [en](https://longbridge.com/en/news/248724388.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248724388.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/248724388.md) | [繁體中文](https://longbridge.com/zh-HK/news/248724388.md)


# Pharmaceutical stocks continued to rise in the afternoon, with LIVZON GROUP and nearly ten other stocks hitting the daily limit

In the afternoon, the pharmaceutical stocks continued to rise, with both innovative drugs and generic drugs performing well. Stocks such as LIVZON GROUP, MEDISAN, Qianhong Pharmaceutical, Wanbangde, Asia-Pacific Pharmaceutical, and ZHEJIANG ZHENYUAN hit the daily limit, while Guangshengtang, Laimei Pharmaceutical, and Wohu Biological rose over 10%. On the news front, the National Organization for Drug Procurement Office announced the selection of the 11th batch of centralized procurement varieties on the 15th. After three stages of screening, 55 varieties were included in the reporting scope of the 11th batch of centralized procurement. The procurement rules will generally adhere to the principles of "stabilizing clinical use, ensuring quality, preventing collusion, and countering internal competition."

### 相关股票

- [MEDISAN (002900.CN)](https://longbridge.com/zh-CN/quote/002900.CN.md)
- [LIVZON GROUP (000513.CN)](https://longbridge.com/zh-CN/quote/000513.CN.md)
- [LIVZON PHARMA (01513.HK)](https://longbridge.com/zh-CN/quote/01513.HK.md)
- [ZHEJIANG ZHENYUAN (000705.CN)](https://longbridge.com/zh-CN/quote/000705.CN.md)

## 相关资讯与研究

- [07:50 ETVACUUM PUMP OIL MIST ELIMINATORS PREVENT CONTAMINATION FROM AIRBORNE OIL DROPLETS](https://longbridge.com/zh-CN/news/278548751.md)
- [Pizu Group Details Tajikistan Mining Loan Deal and Planned 45% Stake in Kanzi Diyor](https://longbridge.com/zh-CN/news/278384508.md)
- [Tencent Holdings is secretly building a new AI agent for its hugely popular WeChat messaging app - The Information](https://longbridge.com/zh-CN/news/278563864.md)
- [13:46 ETNanchang Optoelectronic Industry Cluster brilla en ISLE 2026](https://longbridge.com/zh-CN/news/278597263.md)
- [06:00 ETBlues and Skylo Launch Industry-First Satellite, Cellular, and WiFi in a Single IoT Module](https://longbridge.com/zh-CN/news/278368608.md)